Product
Supplier
Encyclopedia
Inquiry
Home > Biochemical Engineering > Polypeptide > Retatrutide for Sale > Retatrutide Appearance White powdersuppresses appetite increases energy expenditure increases energy expenditure
Retatrutide Appearance White powdersuppresses appetite  increases energy expenditure increases energy expenditure buy - large image1
Retatrutide Appearance White powdersuppresses appetite  increases energy expenditure increases energy expenditure buy - image1
Retatrutide Appearance White powdersuppresses appetite  increases energy expenditure increases energy expenditure buy - image2
Retatrutide Appearance White powdersuppresses appetite  increases energy expenditure increases energy expenditure buy - image3
Retatrutide Appearance White powdersuppresses appetite  increases energy expenditure increases energy expenditure buy - image4
Retatrutide Appearance White powdersuppresses appetite  increases energy expenditure increases energy expenditure buy - image5
Retatrutide Appearance White powdersuppresses appetite  increases energy expenditure increases energy expenditure buy - image6

Retatrutide Appearance White powdersuppresses appetite increases energy expenditure increases energy expenditure

TDS 7375 Inquiries

Unit Price: Get Latest Price
CAS No.:

2381089-83-2

Grade:

Pharmaceutical Grade

Content:

99%

Port:

ShenZhen

Brand:

No brand

Packaging:

5mg 10mg 15mg 20mg 30mg 40mg 60mg 1g

Sample Available:

Yes

Price valid (until):

2026-10-09

Company Type:
Trader
Location:
China
Payment Terms:
TT against copy of documents,100% TT in advance
Qualification:
Main Products:

Peptides,Tirzepatide,Retatrutide,GLP-1,Semaglutide,AMK-CU

  • Product Description

  • Seller Information

  • History Price

  • Inquiry History

  • Description

     whatsapp:+86 13248433458

    Shop Retatrutide Appearance White powdersuppresses appetite  increases energy expenditure increases energy expenditure-Detailed Image 1 Shop Retatrutide Appearance White powdersuppresses appetite  increases energy expenditure increases energy expenditure-Detailed Image 2 Shop Retatrutide Appearance White powdersuppresses appetite  increases energy expenditure increases energy expenditure-Detailed Image 3 Shop Retatrutide Appearance White powdersuppresses appetite  increases energy expenditure increases energy expenditure-Detailed Image 4 Shop Retatrutide Appearance White powdersuppresses appetite  increases energy expenditure increases energy expenditure-Detailed Image 5

    Shop Retatrutide Appearance White powdersuppresses appetite  increases energy expenditure increases energy expenditure-Detailed Image 6

    Main effects reported in literature:
    • Promotes the synthesis of extracellular matrix components such as collagen and elastin, supporting skin regeneration and tissue remodeling research;
    • Facilitates wound healing and angiogenesis (evidences from in‑vitro and animal models);
    • Exerts antioxidant and anti‑inflammatory activities, alleviating skin cell damage caused by oxidative stress;
    • Hair‑care research: stimulates hair follicle cell proliferation and prolongs the anagen phase of hair growth (literature reports);
    • Anti‑aging research: modulates the expression of genes related to DNA repair and extracellular matrix renewal.

    Ordering Information:

    • Standard specifications listed in the catalog are available in stock. For special specifications and batch requirements, please contact our sales team to confirm lead time.

    • Batch traceability: Each batch is assigned a unique batch number. Full COA is available, including purity, molecular weight and sequence verification results.

    • Custom synthesis: We support sequence modifications (acetylation, amidation, fatty acid modification, etc.), fluorescent / biotin labeling, stable isotope labeling and impurity profile control.

    • Technical support: Technical consultation and literature support are provided, covering reconstitution, storage and experimental protocol design.

    • Packaging & Shipping: Standard cold‑chain shipping is offered. Aliquot service is available upon lab request to avoid repeated freeze‑thaw cycles.

    • Customer scope: Products are only supplied to universities, research institutes, hospital laboratories and biomedical enterprises with R&D qualifications.

    To request a quotation, COA sample or custom proposal, please provide product name, purity requirement, packaging specification and receiving laboratoryn iformation. We will reply within one working day.

    FAQ

    Q1: Can I place a trial order for one vial?
    A: Yes, trial orders are acceptable.

    Q2: What payment terms do you support?
    A: We accept T/T, PayPal, bank transfer and other payment methods. Please pick the one most convenient for you.

    Q3: What is the lead time and shipping option?
    A: We ship by international couriers (DHL, UPS, FedEx) or air freight. Delivery time to your address is approximately 8‑10 business days.

    ECHEMI Editorial Reference
    Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). Retatrutide inhibits human GCGR, GIPR and GLP-1R with EC50 values of 5.79, 0.0643 and 0.775 nM, respectively and mouse GCGR, GIPR, and GLP-1R with EC50 values of 2.32, 0.191 and 0.794 nM, respectively. It is an important tool for obesity research.Retatrutide potently activates the GLP-1R signaling pathway to stimulate glucose-dependent insulin secretion through activity at the GIP receptor (GIPR) or the GLP-1R.Retatrutide is a synthetic peptide with glucose-lowering effects. It is an antidiabetic agent against type 2 diabetes (T2D), stimulating insulin and suppressing glucagon secretion in a glucose-dependent manner.Retatrutide was also shown to delay gastric emptying, lower fasting and postprandial glucose concentration, decrease food intake and reduce body weight in patients with type 2 diabetes.
    Retatrutide (LY-3437943) was discovered by the American pharmaceutical company Eli Lilly and Company. It is a triple glucagon hormone receptor agonist (GLP-1, GIP, and GCGR receptors) for obesity. The 2024 Lasker~DeBakey Clinical Medical Research Award has been given to Joel Habener and Svetlana Mojsov for their discovery of a new hormone GLP-1(7-37) and to Lotte Knudsen for her role in developing sustained acting versions of this hormone as a treatment for obesity.

    Certificates

    Basic Info
    Product Name:

    Retatrutide

    Other Name:

    Retatrutide;GIPR/GLP-1R;LY3437943Retatrutide;Retalutide;Retatrutide (sodium salt);Retatrutide RT5;retatrutide 5mg;Retatratide

    CAS No.:

    2381089-83-2

    InChIKeys:

    MLOLQJNKXBNWFW-SAGGEDDASA-N

    Molecular Weight:

    0

    EC Number:

    200-001-8

    Color/Form:

    White lyophilized

    Categories:

    Polypeptide

    Characteristics
    Water Solubility:

    Soluble in water (5mg/ml).

    Storage Conditions:

    -20°C

    Critical Temperature & Pressure:

    -20°C

    Research
    Class:

    Triple agonist — GCGR, GIPR, GLP-1R

    Status:

    Investigational (Phase 3)

    Mechanism:

    Simultaneously activates glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR), and glucagon-like peptide-1 receptor (GLP-1R). Engineered from the native GIP backbone with amino acid substitutions to confer GCGR and GLP-1R activity.

    EC50 (Human GCGR):

    5.79 nM

    EC50 (Mouse GIPR):

    0.191 nM

    EC50 (Mouse GLP1R):

    0.794 nM

    EC50 (Mouse GCGR):

    2.32 nM

    EC50 (Human GLP1R):

    0.775 nM

    EC50 (Human GIPR):

    0.0643 nM

    Source:

    Jastreboff AM, et al. N Engl J Med. 2023;389(6):514-526.DOI

    Clinical Development:

    NCT04881760; NCT05882045; NCT06354660

    References
    ChEMBL:

    CHEMBL5095485

    DrugBank:

    DB18993

    KEGG DRUG:

    D12430

    PubChem:

    PubChem

    Disclaimer:

    Retatrutide is an investigational compound not yet approved by FDA or EMA. This listing is for industrial and laboratory research use only. Product information on ECHEMI is provided for sourcing and specification reference. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.

  • Seller Information
    Business Type:

    Trader

    Main Products:

    Peptides,Tirzepatide,Retatrutide,GLP-1,Semaglutide,AMK-CU

    Location:

    18 Linchang, Wujin district, Changzhou, China

    Payment Terms:

    TT against copy of documents,100% TT in advance

    Total Annual Revenue:

    $5 million-$10 million

    Total Employees:

    51-100

    Year of Establishment:

    2026

    Company Profile

    HANGZHOU PLANOVO BIOTECH CO LTD. was officially established on August 25, 2016, at Linchang Group, Mandun Village, Jiaze Town, Wujin District, Changzhou, Jiangsu Province, China. As an innovative enterprise dedicated to the biotechnology sector, the company has quickly made its mark in the industry through outstanding R&D capabilities, rigorous quality control, and a diversified business portfolio, guided by its corporate philosophy of "Quality First, Customer Supreme, Innovation-driven, Integrity in Service."

    Business Scope

    The company's business covers a wide range of areas:

    • Biotechnology and Medical Device R&D Consulting: Focusing on frontier biotechnology research and driving the translation of scientific achievements into practical applications;

    • Cosmetics Production and Sales: Offering high-quality cosmetic products built on a mature R&D and manufacturing system;

    • Medical Device Manufacturing and Sales: Covering Class I, Class II, and Class III medical devices, strictly in accordance with the approved scope of relevant licenses.

    R&D Strength

    The company has an R&D team composed of senior researchers and professional technical talents who uphold the spirit of innovation and focus on R&D and consulting services in biotechnology and medical device technology. The team continuously explores cutting-edge technologies, dedicated to converting the latest scientific research results into practical applications and providing a steady stream of momentum for product innovation.

    Main Product: Tirzepatide/Retatrutide/Semaglutide/CBL-514/Peptide/GLP-1/GHK-CU/NAD+

  • Weekly Price

    The chart shows the price trend of the product in the past 12 months.

  • Inquiry History
    7375 Inquiries
    Country Product Purchase Quantity Date Posted
    United States

    Retatrutide 2381089-83-2

    3 MT Mar 28, 2026
    United Kingdom

    Retatrutide - 2381089-83-2

    1 G Feb 10, 2026
    United States

    Retatrutide CAS 2381089-83-2 10mg vial

    20 MT Mar 7, 2026
    United States

    Factory Retatrutide API 99% Purity CAS 2381089-83-2

    5 KG Nov 10, 2025
    United Kingdom

    Peptide powder Retatrutide 99% pure for Body building cas 2381089-83-2 Weight Loss Peptide with COA

    1 MT Mar 22, 2026
    United States

    2381089-83-2

    100 G Jul 14, 2026
    United States

    2381089-83-2

    100 G Feb 24, 2026
    United States

    2381089-83-2

    100 MT Dec 9, 2023
    United States

    Retatrutide 2381089-83-2

    200 MG May 16, 2026
    United Kingdom

    2381089-83-2 retatrutide

    300 MG Feb 13, 2026
    United States

    Retatrutide 2381089-83-2 wholesale

    500 MT Nov 3, 2023
    Poland

    CAS 2381089-83-2 (Custom Peptide)

    40 MT Apr 10, 2026
    Austria

    Peptide Retatruide CAS 2381089-83-2

    100 MT Apr 4, 2026
    Austria

    Retatrutide CAS 2381089-83-2 10mg vial

    20 PCS Feb 10, 2026
    United States

    Retatrutide CAS 2381089-83-2 99%

    10 PCS Feb 21, 2026
    United States

    GLP-1 / GIP Retatrutide cas 2381089-83-2

    1 MT Oct 16, 2024
    United States

    Retatrutide 99% High Quality CAS 2381089-83-2

    1 G Jan 23, 2026
    Palestine

    Factory 99% Purity Retatrutide Peptide CAS 2381089-83-2 Door-To-Door Service

    10 MG Mar 16, 2026
    United States

    Factory 99% Purity Retatrutide Peptide CAS 2381089-83-2 Door-To-Door Service

    20 MG Feb 4, 2026
    Singapore

    Factory 99% Purity Retatrutide Peptide CAS 2381089-83-2 Door-To-Door Service

    100 MG Jun 28, 2025
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.